Hennion & Walsh Asset Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
3,304
-50
-1% -$4.24K 0.01% 850
2026
Q1
$280K Sell
3,354
-25
-0.7% -$2.05K 0.01% 841
2025
Q4
$310K Sell
3,379
-75
-2% -$7.18K 0.01% 827
2025
Q3
$327K Sell
3,454
-76
-2% -$7.15K 0.01% 813
2025
Q2
$370K Buy
3,530
+393
+13% +$37.3K 0.01% 761
2025
Q1
$277K Buy
3,137
+897
+40% +$92K 0.01% 775
2024
Q4
$215K Buy
+2,240
New +$209K 0.01% 817
2021
Q4
Sell
-4,081
Closed -$264K 761
2021
Q3
$264K Sell
4,081
-57
-1% -$3.96K 0.01% 652
2021
Q2
$333K Sell
4,138
-3,052
-42% -$233K 0.02% 593
2021
Q1
$489K Buy
+7,190
New +$565K 0.03% 500

Other funds holding HQY

Hennion & Walsh Asset Management's HQY Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its HealthEquity (HQY) stake by 1.5% in Q2 2026, selling an estimated $4.24K and leaving 3,304 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #850.

Hennion & Walsh Asset Management first reported a position in HQY in Q1 2021 and has held it in 10 quarters since. The position peaked at $489K in Q1 2021. 99 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Hennion & Walsh Asset Management held 3,304 shares of HealthEquity worth $298K as of Q2 2026.
  • Hennion & Walsh Asset Management sold 50 HealthEquity shares in Q2 2026, an estimated $4.24K.
  • HealthEquity made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #850 holding.
  • Hennion & Walsh Asset Management first reported a position in HealthEquity in Q1 2021 and has held it in 10 quarters since.
  • Hennion & Walsh Asset Management's HealthEquity position peaked at $489K in Q1 2021.
  • 99 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.